Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 2
Submit an article Journal homepage
520
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study

D. King London School of Economics and Political Science, London, UKCorrespondence[email protected]
,
M. Knapp London School of Economics and Political Science, London, UK
,
P. Thomas Service de Psychiatrie, Hôpital M. Fontan CHRU de Lille, Lille, France
,
D. Razzouk Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil
,
J.-Y. Loze Otsuka Pharmaceutical Europe Ltd, Paris, France
,
H.J. Kan Bristol-Myers Squibb, Wallingford, CT, USA
&
M. van Baardewijk Bristol-Myers Squibb, Parc de l’Alliance, Braine-l’Alleud, Belgium
 show all
Pages 365-374 | Accepted 22 Nov 2010, Published online: 20 Dec 2010

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Natalie C. Edwards, Erik Muser, Dilesh Doshi & John Fastenau. (2012) The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving. Journal of Medical Economics 15:4, pages 623-634.
Read now

Articles from other publishers (7)

Gemma E. Shields, Elizabeth Camacho, Tracey Farragher, Paul Clarkson, Arpana Verma & Linda M. Davies. (2022) Acknowledging Patient Heterogeneity in Economic Evaluations in Schizophrenia: A Systematic Review. Value in Health 25:1, pages 147-156.
Crossref
P. Rocca, C. Montemagni, C. Mingrone, B. Crivelli, M. Sigaudo & F. Bogetto. (2020) A cluster-analytical approach toward real-world outcome in outpatients with stable schizophrenia. European Psychiatry 32, pages 48-54.
Crossref
Gregory Kruse, Bruce J. O. Wong, Mei Sheng Duh, Patrick Lefebvre, Marie-Hélène Lafeuille & John M. Fastenau. (2015) Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. PharmacoEconomics 33:10, pages 1049-1067.
Crossref
Taehwan Park & Karen M. Kuntz. (2014) Cost-Effectiveness of Second-Generation Antipsychotics for the Treatment of Schizophrenia. Value in Health 17:4, pages 310-319.
Crossref
Priya Khanna, Tao Suo, Katja Komossa, Huaixing Ma, Christine Rummel-Kluge, Hany G El-Sayeh, Stefan Leucht & Jun Xia. (2014) Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Priya Khanna, Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Sandra Schwarz, Hany George El-Sayeh & Stefan Leucht. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Jamie D. Croxtall. (2012) Aripiprazole. CNS Drugs 26:2, pages 155-183.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.